Marché du diagnostic des accidents vasculaires cérébraux en Asie-Pacifique – Tendances et prévisions du secteur jusqu’en 2028

Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché du diagnostic des accidents vasculaires cérébraux en Asie-Pacifique – Tendances et prévisions du secteur jusqu’en 2028

  • Medical Devices
  • Publish Reports
  • Oct 2021
  • Asia-Pacific
  • 350 Pages
  • Nombre de tableaux : 134
  • Nombre de figures : 44

>Marché du diagnostic des accidents vasculaires cérébraux en Asie-Pacifique, par gravité (modérée, grave, légère), type (tomodensitométrie (CT Scan), angiographie par tomodensitométrie (CTA), imagerie par résonance magnétique (IRM), angiographie par résonance magnétique (ARM), échographie Doppler transcrânienne , test d'impulsion vidéo de la tête (VHIT), autres), application (accident vasculaire cérébral ischémique, accident vasculaire cérébral hémorragique, attaques ischémiques transitoires (TIAS)), utilisateur final (hôpitaux, cliniques, centres de chirurgie ambulatoire, soins à domicile), canal de distribution (appel d'offres direct, distributeurs tiers, autres), stade (préopératoire, périopératoire, postopératoire), pays (Japon, Chine, Inde, Corée du Sud, Australie, Singapour, Thaïlande, Malaisie, Indonésie, Philippines et reste de l'Asie-Pacifique) Tendances et prévisions de l'industrie jusqu'en 2028

Marché du diagnostic des accidents vasculaires cérébraux en Asie-PacifiqueAnalyse et perspectives du marché : marché du diagnostic des accidents vasculaires cérébraux en Asie-Pacifique

Le marché du diagnostic des accidents vasculaires cérébraux en Asie-Pacifique devrait connaître une croissance du marché au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 11,2 % au cours de la période de prévision de 2021 à 2028 et devrait atteindre 6 969,06 millions USD d'ici 2028. L'augmentation des maladies chroniques et du cancer sont les principaux moteurs qui devraient propulser la demande du marché au cours de la période de prévision.

Un accident vasculaire cérébral survient lorsque l'apport sanguin au cerveau est diminué ou complètement bloqué, ce qui empêche le tissu cérébral de recevoir de l'oxygène et des nutriments. Différents types d'appareils de diagnostic sont utilisés pour détecter un accident vasculaire cérébral et ses premiers symptômes, par exemple la tomodensitométrie (TDM), l'angiographie par tomodensitométrie (CTA), l'imagerie par résonance magnétique (IRM), l'angiographie par résonance magnétique (ARM), l'échographie Doppler transcrânienne et d'autres.

L'incidence croissante des accidents vasculaires cérébraux et des maladies cardiovasculaires et neurologiques a accru la demande de diagnostics d'accidents vasculaires cérébraux dans les pays en développement. En outre, l'augmentation des dépenses de santé stimule la croissance du marché. D'un autre côté, le coût élevé du diagnostic peut freiner la croissance du marché. La présence d'acteurs sur le marché et le lancement de nouveaux produits offrent une opportunité. Cependant, le manque de professionnels qualifiés peut constituer un défi pour le marché.

Le rapport sur le marché du diagnostic des accidents vasculaires cérébraux fournit des détails sur la part de marché, les nouveaux développements, l'impact des acteurs du marché national et local, l'analyse des opportunités en termes de poches de revenus émergentes, les changements dans la réglementation du marché, les approbations de produits , les décisions stratégiques, les lancements de produits, les expansions géographiques et les innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché, contactez-nous pour un briefing d'analyste. Notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.

Marché du diagnostic des accidents vasculaires cérébraux en Asie-PacifiquePortée et taille du marché du diagnostic des accidents vasculaires cérébraux en Asie-Pacifique

Asia-Pacific stroke diagnostics market is categorized into six notable segments which are based on severity, type, application, end users, distribution channel, and stage.

  • On the basis of severity, the Asia-Pacific stroke diagnostics market is segmented into moderate, severe, and mild. In 2021, the moderate segment is expected to dominate the market due to an increase in the patient population of stroke.
  • On the basis of type, the Asia-Pacific stroke diagnostics market is segmented into computed tomography (CT Scan), computed tomography angiography (CTA), magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), transcranial Doppler ultrasound, video head impulse test (VHIT), and others. In 2021, the computed tomography (CT scan) segment is expected to dominate the market due to the increase in cardiovascular disease.
  • On the basis of application, the Asia-Pacific stroke diagnostics market is segmented into an ischemic stroke, hemorrhagic stroke, and transient ischemic attacks (TIAS. In 2021, ischemic stroke is expected to dominate the market with the increasing incidence of ischemic stroke globally.
  • On the basis of end-users, the Asia-Pacific stroke diagnostics market is segmented into hospitals, home healthcare, ambulatory surgical centers, and clinics. In 2021, the hospital segment is expected to dominate the market due to the growing number of chronic diseases such as cardiovascular and neuro.
  • On the basis of distribution channel, the Asia-Pacific stroke diagnostics market is segmented into direct tender, third party distributor, and others. In 2021, direct tender is expected to dominate the market due to growing advancements in technology.
  • On the basis of stage, the Asia-Pacific stroke diagnostics market is segmented into pre operative, peri operative, and post operative. In 2021, pre operative is expected to dominate the market due to the increasing incidence of stroke.

Stroke Diagnostics Market Country Level Analysis

The stroke diagnostics market is analyzed, and market size information is provided on the basis of severity, type, application, end users, distribution channel, and stage.

The countries covered in the stroke diagnostics market report are Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, the Philippines, and the rest of the Asia-Pacific.

The stroke diagnostics segment in the Asia-Pacific region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of the increasing number of stroke diagnostics manufacturers. Japan is leading the growth of the Asia-Pacific stroke diagnostics market, and the hospital segment is expected to dominate the stroke diagnostics segment due to the increasing number of fire incidents in the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.

Increase in FDA Approval is Boosting the Market Growth of Stroke diagnostics

The stroke diagnostics market also provides you with detailed market analysis for every country's growth in the stroke diagnostics industry with stroke diagnostics drugs sales, the impact of advancement in the stroke diagnostics technology, and changes in regulatory scenarios with their support for the stroke diagnostics market. The data is available for the historic period 2011 to 2019.

Competitive Landscape and Stroke Diagnostics Market Share Analysis

Stroke diagnostics market competitive landscape provides details by a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to the stroke diagnostics market.

  • The major companies which are dealing in the Asia-Pacific stroke diagnostics market are Siemens, Koninklijke Philips N.V.,  General Electric Company,  Shenzhen Mindray Bio-Medical Electronics Co., Ltd., FUJIFILM Holdings Corporation, Canon Inc., ALPINION MEDICAL SYSTEMS Co., Ltd, Analogic Corporation, Aspect Imaging Ltd, BPL Medical Technologies, Carestream Health, ESAOTE SPA, FUJIFILM Holdings Corporation, Hologic, Inc., IMRIS, Deerfield Imaging Inc., Medfield Diagnostics AB, MEDTRON AG, Neusoft Corporation, SAMSUNG, Shenzhen Anke High-Tech CO., Ltd., Shimadzu Corporation, SIUI, SternMed GmbH, Stryker, among others.

Many product launches and agreements are also initiated by companies worldwide, which are also accelerating the stroke diagnostics market.

For instances,

  • In February 2021, Koninklijke Philips N.V announced that they had successfully completed the acquisition of BioTelemetry, Inc., a leading U.S.-based provider of remote cardiac diagnostics and monitoring. The acquisition has helped the company add new technological wearable sensing products to their product pipeline
  • En mai 2021, General Electric Company a annoncé l'acquisition de Zionexa, une société française privée qui développe et commercialise des agents d'imagerie pouvant aider les médecins à établir des diagnostics. Cela a aidé l'entreprise à augmenter ses instruments de diagnostic

La collaboration, le lancement de produits, l'expansion commerciale, les récompenses et la reconnaissance, les coentreprises et d'autres stratégies des acteurs du marché améliorent le marché de l'entreprise sur le marché du diagnostic des accidents vasculaires cérébraux, ce qui profite également à l'organisation pour améliorer son offre de diagnostic des accidents vasculaires cérébraux.


SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF ASIA PACIFIC STROKE DIAGNOSTICS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES MODEL

5 EPIDEMIOLOGY

6 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: REGULATIONS

6.1 REGULATION IN THE U.S.

6.2 REGULATION IN EUROPE

6.3 REGULATION IN CHINA

6.4 REGULATION IN JAPAN

6.5 REGULATION IN SOUTH AFRICA

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 TECHNOLOGICAL ADVANCEMENT

7.1.2 INCREASE IN THE INCIDENCE OF STROKE

7.1.3 INCREASE IN THE GERIATRIC POPULATION

7.1.4 INCREASE IN NUMBER OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASES

7.2 RESTRAINTS

7.2.1 HIGH COST OF DIAGNOSIS

7.2.2 INCREASE IN PRODUCT RECALL

7.3 OPPORTUNITIES

7.3.1 RISE IN HEALTHCARE SPENDING

7.3.2 INCREASE IN DIABETIC POPULATION AND OBESITY

7.3.3 INCREASE IN FDA APPROVAL AND PRODUCT LAUNCH

7.3.4 RISE IN AWARENESS REGARDING HEALTH AND STROKE

7.4 CHALLENGES

7.4.1 UNFAVORABLE REIMBURSEMENT SCENARIO

7.4.2 COMPLICATION RELATED TO DIAGNOSTIC DEVICES

8 IMPACT OF COVID-19 ON ASIA PACIFIC STROKE DIAGNOSTICS MARKET

8.1 IMPACT ON PRICE

8.2 IMPACT ON DEMAND

8.3 IMPACT ON SUPPLY CHAIN

8.4 STRATEGIC INITIATIVES

8.5 CONCLUSION

9 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY SEVERITY

9.1 OVERVIEW

9.2 MODERATE

9.3 SEVERE

9.4 MILD

10 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY TYPE

10.1 OVERVIEW

10.2 COMPUTED TOMOGRAPHY (CT SCAN)

10.3 COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA)

10.4 MAGNETIC RESONANCE IMAGING (MRI)

10.5 MAGNETIC RESONANCE ANGIOGRAPHY (MRA)

10.6 TRANSCRANIAL DOPPLER ULTRASOUND

10.7 VIDEO HEAD IMPULSE TEST (VHIT)

10.8 OTHERS

10.8.1 CAROTID ULTRASOUND

10.8.2 CAROTID ANGIOGRAPHY

10.8.3 ELECTROCARDIOGRAPHY (EKG)

10.8.4 ECHOCARDIOGRAPHY

10.8.5 BLOOD TESTS

10.8.6 NUCLEAR NEUROIMAGING

10.8.7 OTHERS

11 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 ISCHEMIC STROKE

11.2.1 THROMBOTIC STROKES

11.2.2 EMBOLIC STROKES

11.3 HEMORRHAGIC STROKE

11.3.1 INTRACEREBRAL HEMORRHAGE

11.3.2 SUBARACHNOID HEMORRHAGE

11.4 TRANSIENT ISCHEMIC ATTACKS (TIAS)

12 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITAL

12.3 CLINICS

12.4 AMBULATORY SURGICAL CENTERS

12.5 HOME HEALTHCARE

12.6 OTHERS

13 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 DIRECT TENDER

13.3 THIRD PARTY DISTRIBUTORS

13.4 OTHERS

14 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY STAGE

14.1 OVERVIEW

14.2 PRE OPERATIVE

14.3 PERI OPERATIVE

14.4 POST OPERATIVE

15 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY REGION

15.1 ASIA-PACIFIC

15.1.1 JAPAN

15.1.2 CHINA

15.1.3 INDIA

15.1.4 SOUTH KOREA

15.1.5 AUSTRALIA

15.1.6 SINGAPORE

15.1.7 THAILAND

15.1.8 MALAYSIA

15.1.9 INDONESIA

15.1.10 PHILIPPINES

15.1.11 REST OF ASIA-PACIFIC

16 STROKE DIAGNOSTICS MARKET COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC

17 SWOT ANALYSIS

18 COMPANY PROFILE

18.1 SIEMENS

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 COMPANY SHARE ANALYSIS

18.1.4 PRODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENTS

18.2 KONINKLIJKE PHILIPS N.V.

18.2.1 COMPANY SNAPSHOT

18.2.2 REVENUE ANALYSIS

18.2.3 COMPANY SHARE ANALYSIS

18.2.4 PRODUCT PORTFOLIO

18.2.5 RECENT DEVELOPMENTS

18.3 GENERAL ELECTRIC COMPANY

18.3.1 COMPANY SNAPSHOT

18.3.2 REVENUE ANALYSIS

18.3.3 COMPANY SHARE ANALYSIS

18.3.4 PRODUCT PORTFOLIO

18.3.5 RECENT DEVELOPMENTS

18.4 CANON INC

18.4.1 COMPANY SNAPSHOT

18.4.2 REVENUE ANALYSIS

18.4.3 COMPANY SHARE ANALYSIS

18.4.4 PRODUCT PORTFOLIO

18.4.5 RECENT DEVELOPMENTS

18.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD

18.5.1 COMPANY SNAPSHOT

18.5.2 REVENUE ANALYSIS

18.5.3 COMPANY SHARE ANALYSIS

18.5.4 PRODUCT PORTFOLIO

18.5.5 RECENT DEVELOPMENTS

18.6 ALPINION MEDICAL SYSTEMS CO., LTD

18.6.1 COMPANY SNAPSHOT

18.6.2 PRODUCT PORTFOLIO

18.6.3 RECENT DEVELOPMENTS

18.7 ANALOGIC CORPORATION

18.7.1 COMPANY SNAPSHOT

18.7.2 PRODUCT PORTFOLIO

18.7.3 RECENT DEVELOPMENT

18.8 ASPECT IMAGING LTD

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENT

18.9 BPL MEDICAL TECHNOLOGIES

18.9.1 COMPANY SNAPSHOT

18.9.2 PRODUCT PORTFOLIO

18.9.3 RECENT DEVELOPMENT

18.1 CARESTREAM HEALTH

18.10.1 COMPANY SNAPSHOT

18.10.2 REVENUE ANALYSIS

18.10.3 PRODUCT PORTFOLIO

18.10.4 RECENT DEVELOPMENTS

18.11 ESAOTE SPA

18.11.1 COMPANY SNAPSHOT

18.11.2 PRODUCT PORTFOLIO

18.11.3 RECENT DEVELOPMENTS

18.12 FONAR CORP

18.12.1 COMPANY SNAPSHOT

18.12.2 REVENUE ANALYSIS

18.12.3 PRODUCT PORTFOLIO

18.12.4 RECENT DEVELOPMENT

18.13 FUJIFILM HOLDINGS CORPORATION

18.13.1 COMPANY SNAPSHOT

18.13.2 REVENUE ANALYSIS

18.13.3 PRODUCT PORTFOLIO

18.13.4 RECENT DEVELOPMENTS

18.14 HOLOGIC, INC

18.14.1 COMPANY SNAPSHOT

18.14.2 REVENUE ANALYSIS

18.14.3 PRODUCT PORTFOLIO

18.14.4 RECENT DEVELOPMENTS

18.15 IMRIS, DEERFIELD IMAGING INC.

18.15.1 COMPANY SNAPSHOT

18.15.2 PRODUCT PORTFOLIO

18.15.3 RECENT DEVELOPMENT

18.16 MEDFIELD DIAGNOSTICS AB

18.16.1 COMPANY SNAPSHOT

18.16.2 PRODUCT PORTFOLIO

18.16.3 RECENT DEVELOPMENT

18.17 MEDTRON AG

18.17.1 COMPANY SNAPSHOT

18.17.2 PRODUCT PORTFOLIO

18.17.3 RECENT DEVELOPMENT

18.18 NEUSOFT CORPORATION

18.18.1 COMPANY SNAPSHOT

18.18.2 REVENUE ANALYSIS

18.18.3 PRODUCT PORTFOLIO

18.18.4 RECENT DEVELOPMENT

18.19 SAMSUNG

18.19.1 COMPANY SNAPSHOT

18.19.2 REVENUE ANALYSIS

18.19.3 PRODUCT PORTFOLIO

18.19.4 RECENT DEVELOPMENTS

18.2 SHENXHEN ANKE HIGH-TECH CO., LTD.

18.20.1 COMPANY SNAPSHOT

18.20.2 PRODUCT PORTFOLIO

18.20.3 RECENT DEVELOPMENT

18.21 SHIMADZU CORPORATION

18.21.1 COMPANY SNAPSHOT

18.21.2 REVENUE ANALYSIS

18.21.3 PRODUCT PORTFOLIO

18.21.4 RECENT DEVELOPMENTS

18.22 SIUI

18.22.1 COMPANY SNAPSHOT

18.22.2 PRODUCT PORTFOLIO

18.22.3 RECENT DEVELOPMENTS

18.23 STERNMED GMBH

18.23.1 COMPANY SNAPSHOT

18.23.2 PRODUCT PORTFOLIO

18.23.3 RECENT DEVELOPMENT

18.24 STRYKER

18.24.1 COMPANY SNAPSHOT

18.24.2 REVENUE ANALYSIS

18.24.3 PRODUCT PORTFOLIO

18.24.4 RECENT DEVELOPMENTS

18.25 TERASON DIVISION TERATECH CORPORATION

18.25.1 COMPANY SNAPSHOT

18.25.2 PRODUCT PORTFOLIO

18.25.3 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

Liste des tableaux

TABLE 1 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 2 ASIA PACIFIC MODERATE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 ASIA PACIFIC SEVERE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 4 ASIA PACIFIC MILD IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 5 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 6 ASIA PACIFIC COMPUTED TOMOGRAPHY (CT SCAN) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 ASIA PACIFIC COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 8 ASIA PACIFIC MAGNETIC RESONANCE IMAGING (MRI) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 ASIA PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY (MRA) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 ASIA PACIFIC TRANSCRANIAL DOPPLER ULTRASOUND IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 ASIA PACIFIC VIDEO HEAD IMPULSE TEST (VHIT) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 ASIA PACIFIC OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 ASIA PACIFIC OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 14 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 15 ASIA PACIFIC ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 ASIA PACIFIC ISCHEMIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 17 ASIA PACIFIC HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 ASIA PACIFIC HEMORRHAGIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 19 ASIA PACIFIC TRANSIENT ISCHEMIC ATTACKS (TIAS) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 21 ASIA PACIFIC HOSPITAL IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 ASIA PACIFIC CLINICS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 ASIA PACIFIC AMBULATORY SURGICAL CENTERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 ASIA PACIFIC HOME HEALTHCARE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 ASIA PACIFIC OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 27 ASIA PACIFIC DIRECT TENDER IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 ASIA PACIFIC THIRD PARTY DISTRIBUTORS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 ASIA PACIFIC OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 ASIA PACIFIC STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 31 ASIA PACIFIC PRE OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 ASIA PACIFIC PERI OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 ASIA PACIFIC POST OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 35 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 36 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 37 ASIA-PACIFIC OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 38 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 39 ASIA-PACIFIC ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 40 ASIA-PACIFIC HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 41 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 42 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 43 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 44 JAPAN STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 45 JAPAN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 46 JAPAN OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 47 JAPAN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 48 JAPAN ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 49 JAPAN HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 50 JAPAN STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 51 JAPAN STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 52 JAPAN STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 53 CHINA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 54 CHINA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 55 CHINA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 56 CHINA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 57 CHINA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 58 CHINA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 59 CHINA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 60 CHINA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 61 CHINA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 62 INDIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 63 INDIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 64 INDIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 65 INDIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 66 INDIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 67 INDIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 68 INDIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 69 INDIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 70 INDIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 71 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 72 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 73 SOUTH KOREA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 74 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 75 SOUTH KOREA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 76 SOUTH KOREA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 77 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 78 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 79 SOUTH KOREA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 80 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 81 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 82 AUSTRALIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 83 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 84 AUSTRALIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 85 AUSTRALIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 86 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 87 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 88 AUSTRALIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 89 SINGAPORE STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 90 SINGAPORE STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 91 SINGAPORE OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 92 SINGAPORE STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 93 SINGAPORE ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 94 SINGAPORE HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 95 SINGAPORE STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 96 SINGAPORE STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 97 SINGAPORE STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 98 THAILAND STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 99 THAILAND STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 100 THAILAND OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 101 THAILAND STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 102 THAILAND ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 103 THAILAND HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 104 THAILAND STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 105 THAILAND STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 106 THAILAND STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 107 MALAYSIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 108 MALAYSIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 109 MALAYSIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 110 MALAYSIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 111 MALAYSIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 112 MALAYSIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 113 MALAYSIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 114 MALAYSIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 115 MALAYSIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 116 INDONESIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 117 INDONESIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 118 INDONESIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 119 INDONESIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 120 INDONESIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 121 INDONESIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 122 INDONESIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 123 INDONESIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 124 INDONESIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 125 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

TABLE 126 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 127 PHILIPPINES OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 128 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 129 PHILIPPINES ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 130 PHILIPPINES HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 131 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 132 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 133 PHILIPPINES STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 134 REST OF ASIA-PACIFIC STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)

Liste des figures

FIGURE 1 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 2 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: DATA TRIANGULATION

FIGURE 3 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: DROC ANALYSIS

FIGURE 4 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS

FIGURE 5 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 11 THE INCREASE IN DEMAND FOR STROKE DIAGNOSTISIS EXPECTED TO DRIVE THE ASIA PACIFIC STROKE DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 MODERATE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC STROKE DIAGNOSTICS MARKET IN 2021 & 2028

FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC STROKE DIAGNOSTICS MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC STROKE DIAGNOSTICS MARKET

FIGURE 15 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY SEVERITY, 2020

FIGURE 16 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY SEVERITY, 2020-2028 (USD MILLION)

FIGURE 17 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY SEVERITY, CAGR (2021-2028)

FIGURE 18 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY SEVERITY, LIFELINE CURVE

FIGURE 19 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY TYPE, 2020

FIGURE 20 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY TYPE, 2020-2028 (USD MILLION)

FIGURE 21 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 22 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 23 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY APPLICATION, 2020

FIGURE 24 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY APPLICATION, 2020-2028 (USD MILLION)

FIGURE 25 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY APPLICATION, CAGR (2021-2028)

FIGURE 26 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 27 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY END USER, 2020

FIGURE 28 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY END USER, 2020-2028 (USD MILLION)

FIGURE 29 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY END USER, CAGR (2021-2028)

FIGURE 30 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE

FIGURE 31 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 32 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)

FIGURE 33 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 34 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 35 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY STAGE, 2020

FIGURE 36 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY STAGE, 2020-2028 (USD MILLION)

FIGURE 37 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY STAGE, CAGR (2021-2028)

FIGURE 38 ASIA PACIFIC STROKE DIAGNOSTICS MARKET: BY STAGE, LIFELINE CURVE

FIGURE 39 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET: SNAPSHOT (2020)

FIGURE 40 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET: BY COUNTRY (2020)

FIGURE 41 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 42 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 43 ASIA-PACIFIC STROKE DIAGNOSTICS MARKET: BY SEVERITY (2021-2028)

FIGURE 44 STROKE DIAGNOSTICS MARKET COMPANY SHARE 2020 (%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.